↓ Skip to main content

The cost-utility of aflibercept for the treatment of age-related macular degeneration compared to bevacizumab and ranibizumab and the influence of model parameters

Overview of attention for article published in Graefe's Archive for Clinical and Experimental Ophthalmology, April 2014
Altmetric Badge

Mentioned by

policy
3 policy sources
twitter
1 X user

Citations

dimensions_citation
53 Dimensions

Readers on

mendeley
90 Mendeley